Do not combine GLP-1 therapies unless a clinician specifically instructs you to do so
Nevertheless, a systematic assessment of their therapeutic applications, mechanisms, and clinical translation challenges in IMIDs remains lacking
"If this risk was carried over millions of users, those affected could end up being a sizable group of patients," VanderBeek noted
Just one thing. Next, he showed me a graph that looked like a jagged roller coaster
What FDA-Approved GLP-1 Medications Exist in 2026 Seven distinct molecules, several brand names: Semaglutide Ozempic (diabetes injection), Wegovy (weight-loss injection and oral), Rybelsus (diabetes oral) Tirzepatide Mounjaro (diabetes injection), Zepbound (weight-loss injection and OSA) Liraglutide Victoza (diabetes injection, daily), Saxenda (weight-loss injection, daily) Dulaglutide Trulicity (diabetes injection, weekly) Exenatide Byetta, Bydureon (diabetes injection) See our complete GLP-1 drug guide for detail on each
Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C, et al